ADURO BIOTECH, INC.·4

Mar 21, 5:35 PM ET

van Elsas Andrea 4

4 · ADURO BIOTECH, INC. · Filed Mar 21, 2019

Insider Transaction Report

Form 4
Period: 2019-03-19
van Elsas Andrea
Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2019-03-19$3.96/sh6,081$24,107239,557 total
Footnotes (2)
  • [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2018.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.91 to $4.09, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4